Application of the Gaussian mixture model to drug dissolution profiles prediction

Neural Computing and Applications

Volumn 14, Issue 4, 2005, Pages 345-352

  Lim, Chee Peng ^a   Quek, Siow San ^a   Peh, Koh Khiang ^b  

^a SCHOOL OF CHEMICAL ENGINEERING   (Malaysia)

^b SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

Artificial neural networks; Bootstrap; Drug dissolution profile prediction; Gaussian mixture model; Parzen window estimation

Indexed keywords

EID: 27744476933     PISSN: 09410643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00521-005-0471-2     Document Type: Article

References (21)

1. Wagner JG (1975) Fundamentals of clinical pharmacokinetics. Drug Intelligence Publications Inc., Hamilton
2. Ette EI, Howie CA, Kelman AW, Whiting B (1995) Experimental design and efficient parameter estimation in preclinical pharmacokinetic studies. Pharm Res 12:729-737
3. Obata Y, Li CJ, Fujikawa M, Takayama K, Sato H, Higashiyama K, Isowa K, Nagai T (2001) Evaluation and structure-activity relationship of synthesized cyclohexanol derivatives on percutaneous absorption of ketoprofen using artificial neural network. Int J Pharm 212:223-231
4. Nishizawa K, Hirano M, Yamamura S, Momose Y, Kimura A, Mochizuki T, Yamamoto Y (1998) Prediction of plasma levels of aminoglycoside antibiotic in patients with severe illness by means of an artificial neural network simulator. J Pharm & Pharm Sci 1:95-101
5. Brier ME, Aronoff GR (1996) Application of artificial neural networks to clinical pharmacology. Int J Clin Pharmacol Ther 34(11):510-514
6. Smith BP, Brier ME (1995) Empirical pharmacodynamic predictions using neural networks: comparison to NONMEM. Pharm Res 12(Suppl.):S328
7. Tolle KM, Chen H, Chow HH (2000) Estimating drug/plasma concentration levels by applying neural networks to pharmacokinetic data sets. Decis Support Syst 30:139-151
8. Hussain AS, Yu X, Johnson RD (1991) Application of neural computing in pharmaceutical product development. Pharm Res 8:1248-1252
9. Brier ME, Zurada JM, Aronoff GR (1995) Neural network predicted peak and trough gentamicin concentrations. Pharm Res 12:406-412
10. Takahara J, Takayama K, Nagai T (1997) Multi-objective simultaneous optimisation based on artificial neural network in sustained released formulations. J Contr Rel 49:11-20
11. Takahara J, Takayama K, Isowa K, Nagai T (1997) Multi-objective simultaneous optimisation based on artificial neural network in a ketoprofen hydrogel formula containing O-ethylmenthol as a percutaneous absorption enhancer. Int J Pharm 15:203-210
12. Bishop CM (1995) Neural network for pattern recognition. Clarendon Press, Oxford
13. Leonard JA, Kramer MA, Unger LH (1992) A neural network architecture that computes its own reliability. Comput Chem Eng 16:819-835
14. Efron, Tibshirani R (1993) An introduction to the Bootstrap. Chapman & Hall, London
15. Box GEP, Jenkins GM (1970) Times series analysis, forecasting and control. Holden Day, San Francisco
16. Sugeno M, Tanaka K (1991) Successive identification of a fuzzy model and its applications to prediction of a complex system. Fuzzy Sets Syst 42:315-334
17. Wang L, Langari R (1995) Building Sugeno-type models using fuzzy discretization and orthogonal parameter estimation techniques. IEEE Trans Fuzzy Syst 3:454-458
18. Kim E, Park M (1997) A new approach to fuzzy modelling. IEEE Trans Fuzzy Syst 5(3):328-337
19. Peh K.K, Yuen KH (1995) Development and in vitro evaluation of a novel multi-particulate matrix controlled release formulation of theophylline. Drug Dev Ind Pharm 21:1545-1555
20. FDA guidance for industry: dissolution testing of immediate release solid oral dossage forms, August 1997
21. Goh WY, Lim CP, Peh K.K (2003) Predicting drug dissolution profiles with an ensemble of boosted neural networks: a time-series approach. IEEE Trans on Neural Netw 14:459-463